Allied Healthcare Products (AHPIQ) Form 4 ALLIED HEALTHCARE PRODUCTS / JOHN D WEIL ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

WEIL JOHN D

(Last) (First) (Middle)

4625 LINDELL BLVD., #335

(Street)

ST. LOUIS MO 63108

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLIED HEALTHCARE PRODUCTS INC [ AHPI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2021		S		69,249	D	$8.437(1)	25,178(2)	I	Spouse
Common Stock	11/26/2021		S		59,101	D	$8.467(1)	0(3)	I	Trust
Common Stock	11/26/2021		S		7,514	D	$8.0565(1)	0(4)	I	Corporation
Common Stock								53,810(5)	I	Trust
Common Stock								90,513	D
Common Stock								2,500	I	IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$5.09	11/11/2021	11/11/2021	A		750		11/11/2022	11/11/2031	Common stock	750(6)	$0	750	D
Option to purchase common stock	$5.18							11/08/2013	11/08/2022	Common stock	750		750	D
Option to purchase common stock	$4.62							11/14/2014	11/14/2023	Common stock	750		750	D
Option to purchase common stock	$3.16							11/13/2015	11/13/2024	Common stock	750		750	D
Option to purchase common stock	$2.34							11/12/2016	11/12/2025	Common stock	750		750	D
Option to purchase common stock	$2.26							11/10/2017	11/10/2026	Common stock	750		750	D
Option to purchase common stock	$2.22							11/09/2018	11/09/2027	Common stock	750		750	D
Option to purchase common stock	$2.13							11/08/2019	11/08/2028	Common stock	750		750	D
Option to purchase common stock	$1.17							11/07/2020	11/07/2029	Common stock	750		750	D
Option to purchase common stock	$7.86							11/12/2021	11/12/2030	Common stock	750		750	D

Explanation of Responses:

1. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. The reporting person disclaims any economic benefit in such shares.

3. Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.

4. Owned by a corporation controlled by the reporting person.

5. Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares. The decrease of 6,710 reported shares between the amount reported in this filing and the amount reported in the most recent previous filing is due to omission of a trust for which the reporting person no longer serves as trustee and with respect to which the reporting person no longer has any pecuniary interest.

6. Issued pursuant to the Company's 2013 Director's Stock Option Plan.

	/s/ John D. Weil	11/30/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.